DJIA 16,204.97 -211.61 -1.29%
NASDAQ 4,363.14 -146.42 -3.25%
S&P 500 1,880.05 -35.40 -1.85%
market minute promo

Vertex Pharmaceuticals (NASDAQ: VRTX)

86.61 -5.11 (-5.57%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

VRTX $86.61 -5.57%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $89.78
Previous Close $91.72
Daily Range $84.54 - $92.23
52-Week Range $81.98 - $143.45
Market Cap $21.3B
P/E Ratio -39.71
Dividend (Yield) $0.00 (0.0%)
Volume 4,571,268
Average Daily Volume 2,645,861
Current FY EPS -$2.28




Drug Makers

Vertex Pharmaceuticals (VRTX) Description

The Company is in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases. Website:

News & Commentary

Vertex Pharmaceuticals Inc.'s Q4 Revenues Surge on New Drug

The biotech's newest drug, cystic fibrosis treatment Orkambi, is now its top-selling asset.

Here's Why Shares Of Vertex Pharmaceuticals Tumbled

Health Care Sector Update for 02/05/2016: JNJ, PFE, ABT, MRK, AMGN, IMMU, VRTX

Health Care Sector Update for 02/05/2016: VRTX, DHRM

Ignore Regeneron Pharmaceuticals, Inc: Here Are 3 Better Buys Right Now

Thinking about investing in Regeneron? Here are three names you might want to consider instead.

Vertex A Buy On Orkambi Revenue And Pipeline

Biotech String: Assessing the January Damage, Gilead's Bottoming P/E, Sarepta Panel Date?

3 Key FDA Decisions Expected in February

What's in Store for Nivalis (NVLS) this Earnings Season?

Here Are the 5 Worst-Performing Stocks in the S&P 500 in 2016

See More VRTX News...

VRTX's Top Competitors

VRTX $86.61 (-5.57%)
Current stock: VRTX
AMGN $145.04 (-3.25%)
Current stock: AMGN
GILD $85.14 (-1.78%)
Current stock: GILD
BIIB $263.86 (-3.44%)
Current stock: BIIB